Hikma Pharmaceuticals PLC announced the following changes to its board of directors and their responsibilities: Dr. Pamela Kirby has decided not to stand for re-election at the next annual general meeting of the Company that is scheduled to take place on 25 April 2022; and Nina Henderson will take over as chair of the Remuneration Committee with effect from the end of the annual general meeting.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,979 GBX | +0.05% | -1.65% | +10.61% |
May. 17 | HIKMA PHARMACEUTICALS : Time to capitalise on Hikma’s ongoing (share price) momentum | |
May. 03 | Deutsche Bank Starts Hikma Pharmaceuticals Coverage at Buy | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+10.61% | 5.58B | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+13.74% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- HIK Stock
- News Hikma Pharmaceuticals PLC
- Hikma Pharmaceuticals Announces Directorate Change